{
    "organizations": [],
    "uuid": "01c7df2a32af9fc71d71ac2db8b8c46cf9a21028",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sanbio-and-unit-receive-subsidy-of/brief-sanbio-and-unit-receive-subsidy-of-4-5-mln-from-cirm-idUSL4N1PO1BF",
    "ord_in_thread": 0,
    "title": "BRIEF-SanBio and unit receive subsidy of $4.5 mln from CIRM",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) - SanBio Co Ltd\n* Says it and unit SanBio, Inc., received subsidy of $4.5 million from CIRM, for chronic cerebral infarction related clinical trials, on Jan. 26 (the U.S. time)\nSource text in Japanese: goo.gl/Se5zCc\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-29T10:01:00.000+02:00",
    "crawled": "2018-01-29T21:58:26.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "sanbio",
        "co",
        "ltd",
        "say",
        "unit",
        "sanbio",
        "received",
        "subsidy",
        "million",
        "cirm",
        "chronic",
        "cerebral",
        "infarction",
        "related",
        "clinical",
        "trial",
        "time",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}